It may be that we should continue treatment in people who have had cardiovascular disease, even if they dont lose as much weight as we would like. This is already the case in the United States where, in March 2024, the US Food and Drug Administration approved Wegovy to treat adults with cardiovascular disease who also have obesity or are overweight but without diabetes mellitus
Semaglutide is a medication that works by releasing a hormone called GLP-1, which helps regulate blood sugar levels and reduce appetite
SeekPeptides has tracked side effect patterns across thousands of research protocols, and the patterns tell a consistent story
Instead of fighting hunger or willpower, your body sends stronger fullness signals that guide you to healthier eating patterns
By utilizing our comprehensive services, including prescription medications and personalized support, we can help you navigate your journey toward a healthier lifestyle with confidence